InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Oct 28, 2025 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Oct 28, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, 8-k, disclosure
TL;DR
InfuSystem Holdings filed an 8-K for a Reg FD disclosure. Details TBD.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on October 28, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report required by the SEC.
Why It Matters
This filing indicates InfuSystem Holdings is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.
Risk Assessment
Risk Level: low — This is a standard regulatory filing without immediate financial implications disclosed.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- 0001337013 (company) — Central Index Key
- 203341405 (company) — EIN
- 3851 West Hamlin Road (company) — Principal Executive Offices Street
- Rochester Hills (company) — Principal Executive Offices City
- MI (company) — Principal Executive Offices State
- 48309 (company) — Principal Executive Offices ZIP
- (248) 291-1210 (company) — Registrant's telephone number
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure, only that it is being made.
When was this 8-K filing submitted?
The filing was submitted on October 28, 2025.
What is the primary business of InfuSystem Holdings, Inc.?
InfuSystem Holdings, Inc. is in the Surgical & Medical Instruments & Apparatus industry (SIC 3841).
What is the company's state of incorporation?
The company is incorporated in Delaware.
What was the former name of InfuSystem Holdings, Inc.?
The company was formerly known as HAPC, Inc. and Healthcare Acquisition Partners Corp.
Filing Stats: 558 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-10-28 16:08:26
Filing Documents
- infu-20251028.htm (8-K) — 27KB
- exhibit991announcementofea.htm (EX-99.1) — 8KB
- infusystem_safesmarttruste.jpg (GRAPHIC) — 760KB
- 0001628280-25-046748.txt ( ) — 1188KB
- infu-20251028.xsd (EX-101.SCH) — 2KB
- infu-20251028_lab.xml (EX-101.LAB) — 21KB
- infu-20251028_pre.xml (EX-101.PRE) — 12KB
- infu-20251028_htm.xml (XML) — 3KB
01 - Regulation FD
Item 7.01 - Regulation FD On October 28, 2025 , InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that the Company will disclose its financial results for the third quarter 2025 on Tuesday, November 4, 2025 before the market opens. The Company will also conduct a conference call for all interested investors on Tuesday, November 4, 2025 at 9:00 a.m. Eastern Time. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated October 28, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Carrie Lachance Carrie Lachance Chief Executive Officer and Director Dated: October 28, 2025